145 related articles for article (PubMed ID: 11198480)
1. In vivo electroporation of plasmids encoding GM-CSF or interleukin-2 into existing B16 melanomas combined with electrochemotherapy induces long-term antitumour immunity.
Heller L; Pottinger C; Jaroszeski MJ; Gilbert R; Heller R
Melanoma Res; 2000 Dec; 10(6):577-83. PubMed ID: 11198480
[TBL] [Abstract][Full Text] [Related]
2. Ex vivo and in vivo adenovirus-mediated gene therapy strategies induce a systemic anti-tumor immune defence in the B16 melanoma model.
Bonnekoh B; Greenhalgh DA; Chen SH; Block A; Rich SS; Krieg T; Woo SL; Roop DR
J Invest Dermatol; 1998 Jun; 110(6):867-71. PubMed ID: 9620291
[TBL] [Abstract][Full Text] [Related]
3. Granulocyte-macrophage colony-stimulating factor (GM-CSF) secreted by cDNA-transfected tumor cells induces a more potent antitumor response than exogenous GM-CSF.
Shi FS; Weber S; Gan J; Rakhmilevich AL; Mahvi DM
Cancer Gene Ther; 1999; 6(1):81-8. PubMed ID: 10078967
[TBL] [Abstract][Full Text] [Related]
4. A new mouse model of experimental melanoma for vaccine and lymphokine therapy.
Shrayer DP; Bogaars H; Wolf SF; Hearing VJ; Wanebo HJ
Int J Oncol; 1998 Aug; 13(2):361-74. PubMed ID: 9664134
[TBL] [Abstract][Full Text] [Related]
5. Granulocyte-macrophage colony-stimulating factor and interleukin-2 fusion cDNA for cancer gene immunotherapy.
Stagg J; Wu JH; Bouganim N; Galipeau J
Cancer Res; 2004 Dec; 64(24):8795-9. PubMed ID: 15604233
[TBL] [Abstract][Full Text] [Related]
6. Effective particle-mediated vaccination against mouse melanoma by coadministration of plasmid DNA encoding Gp100 and granulocyte-macrophage colony-stimulating factor.
Rakhmilevich AL; Imboden M; Hao Z; Macklin MD; Roberts T; Wright KM; Albertini MR; Yang NS; Sondel PM
Clin Cancer Res; 2001 Apr; 7(4):952-61. PubMed ID: 11309346
[TBL] [Abstract][Full Text] [Related]
7. Properties of bcr-abl-transformed mouse 12B1 cells secreting interleukin-2 and granulocyte-macrophage colony-stimulating factor: I. Derivation, genetic stability, oncogenicity and immunogenicity.
Petráčková M; Tachezy R; Vonka V
Int J Oncol; 2012 May; 40(5):1668-76. PubMed ID: 22327125
[TBL] [Abstract][Full Text] [Related]
8. Therapy of established tumour with a hybrid cellular vaccine generated by using granulocyte-macrophage colony-stimulating factor genetically modified dendritic cells.
Cao X; Zhang W; Wang J; Zhang M; Huang X; Hamada H; Chen W
Immunology; 1999 Aug; 97(4):616-25. PubMed ID: 10457215
[TBL] [Abstract][Full Text] [Related]
9. Co-expression of granulocyte-macrophage colony-stimulating factor with antigen enhances humoral and tumor immunity after DNA vaccination.
Sun X; Hodge LM; Jones HP; Tabor L; Simecka JW
Vaccine; 2002 Jan; 20(9-10):1466-74. PubMed ID: 11818167
[TBL] [Abstract][Full Text] [Related]
10. Novel membrane-bound GM-CSF vaccines for the treatment of cancer: generation and evaluation of mbGM-CSF mouse B16F10 melanoma cell vaccine.
Yei S; Bartholomew RM; Pezzoli P; Gutierrez A; Gouveia E; Bassett D; Soo Hoo W; Carlo DJ
Gene Ther; 2002 Oct; 9(19):1302-11. PubMed ID: 12224013
[TBL] [Abstract][Full Text] [Related]
11. Targeting of cytokine gene expression to malignant melanoma cells using tissue specific promoter sequences.
Vile RG; Hart IR
Ann Oncol; 1994; 5 Suppl 4():59-65. PubMed ID: 8060899
[TBL] [Abstract][Full Text] [Related]
12. Complete regression of established subcutaneous B16 murine melanoma tumors after delivery of an HIV-1 Vpr-expressing plasmid by in vivo electroporation.
McCray AN; Ugen KE; Muthumani K; Kim JJ; Weiner DB; Heller R
Mol Ther; 2006 Nov; 14(5):647-55. PubMed ID: 16950655
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of murine melanoma growth by granulocyte-macrophage colony stimulating factor gene transfection is not haplotype specific.
Botella R; Sarradet MD; Potter LE; Lawley M; Galloway TH; Ansel JC; Armstrong CA
Melanoma Res; 1998 Jun; 8(3):245-54. PubMed ID: 9664146
[TBL] [Abstract][Full Text] [Related]
14. Electrochemo-gene therapy of cancer: intratumoral delivery of interleukin-12 gene and bleomycin synergistically induced therapeutic immunity and suppressed subcutaneous and metastatic melanomas in mice.
Kishida T; Asada H; Itokawa Y; Yasutomi K; Shin-Ya M; Gojo S; Cui FD; Ueda Y; Yamagishi H; Imanishi J; Mazda O
Mol Ther; 2003 Nov; 8(5):738-45. PubMed ID: 14599806
[TBL] [Abstract][Full Text] [Related]
15. Vaccination with irradiated, autologous melanoma cells engineered to secrete granulocyte-macrophage colony-stimulating factor by adenoviral-mediated gene transfer augments antitumor immunity in patients with metastatic melanoma.
Soiffer R; Hodi FS; Haluska F; Jung K; Gillessen S; Singer S; Tanabe K; Duda R; Mentzer S; Jaklitsch M; Bueno R; Clift S; Hardy S; Neuberg D; Mulligan R; Webb I; Mihm M; Dranoff G
J Clin Oncol; 2003 Sep; 21(17):3343-50. PubMed ID: 12947071
[TBL] [Abstract][Full Text] [Related]
16. Combination of CD80 and granulocyte-macrophage colony-stimulating factor coexpression by a leukemia cell vaccine: preclinical studies in a murine model recapitulating Philadelphia chromosome-positive acute lymphoblastic leukemia.
Stripecke R; Skelton DC; Pattengale PK; Shimada H; Kohn DB
Hum Gene Ther; 1999 Sep; 10(13):2109-22. PubMed ID: 10498243
[TBL] [Abstract][Full Text] [Related]
17. Anti-tumour activity against B16-F10 melanoma with a GM-CSF secreting allogeneic tumour cell vaccine.
Kayaga J; Souberbielle BE; Sheikh N; Morrow WJ; Scott-Taylor T; Vile R; Chong H; Dalgleish AG
Gene Ther; 1999 Aug; 6(8):1475-81. PubMed ID: 10467372
[TBL] [Abstract][Full Text] [Related]
18. Irreversible electroporation facilitates gene transfer of a GM-CSF plasmid with a local and systemic response.
Au JT; Mittra A; Song TJ; Cavnar M; Jun K; Carson J; Gholami S; Haddad D; Gaujoux S; Monette S; Ezell P; Wolchok J; Fong Y
Surgery; 2013 Sep; 154(3):496-503. PubMed ID: 23972655
[TBL] [Abstract][Full Text] [Related]
19. Anti-tumor effect of in vivo IL-2 and GM-CSF electrogene therapy in murine hepatoma model.
Chi CH; Wang YS; Lai YS; Chi KH
Anticancer Res; 2003; 23(1A):315-21. PubMed ID: 12680230
[TBL] [Abstract][Full Text] [Related]
20. Co-delivery of plasmid-encoded cytokines modulates the immune response to a DNA vaccine delivered by in vivo electroporation.
Yen HH; Scheerlinck JP
Vaccine; 2007 Mar; 25(14):2575-82. PubMed ID: 17224210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
